Perrigo Co. PLC has secured the successful prescription-to-OTC switch of a sildenafil generic, which will soon be available in direct competition to Pfizer’s erectile dysfunction drug, Viagra Connect.
Viagra Connect – which launched in Spring 2018 – has until recently enjoyed de facto market exclusivity in the UK...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?